| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 10k | $26.99 | $269.9k | | 06/08/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 20k | $4.60 | $92k | | 06/08/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 30k | $3.46 | $103.8k | | 06/08/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 14.9k | $4.56 | $67.9k | | 06/08/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 12.8k | $1.04 | $13.3k | | 06/08/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 12.8k | $0.90 | $11.5k | | 06/08/2023 |
| 03/29/2023 | ACHIEVE LIFE SCIENCES, INC. | ACHV | Grant | Stock Option (right to buy) | 23.2k | $5.97 | $138.8k | | 03/29/2023 |
| 06/03/2022 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 30k | $3.46 | $103.8k | | 06/03/2022 |
| 12/03/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 20k | $4.60 | $92k | | 12/03/2020 |
| 06/12/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 10k | $26.99 | $269.9k | | 06/12/2020 |
| 02/20/2020 | VIVUS INC | VVUS | Grant | Non-Qualified Stock Option (Right to Buy) | 15k | $2.41 | $36.2k | | 02/20/2020 |
| 10/26/2018 | VIVUS INC | VVUS | Grant | Non-Qualified Stock Option (Right to Buy) | 15k | $3.53 | $53k | | 10/26/2018 |
| 06/15/2018 | VIVUS INC | VVUS | Grant | Employee Stock Option (right to buy) | 200k | $0.84 | $168k | | 06/15/2018 |
| 01/26/2018 | VIVUS INC | VVUS | Grant | Employee Stock Option (right to buy) | 600k | $0.46 | $276k | | 01/26/2018 |
| 03/29/2013 | Alexza Pharmaceuticals Inc. | ALXA | Grant | Common Stock | 175k | $4.42 | $773.5k | | 03/29/2013 |
| 03/29/2013 | Alexza Pharmaceuticals Inc. | ALXA | Grant | Stock Option (right to buy) | 350k | $4.42 | $1.5M | | 03/29/2013 |